Access earnings results, analyst expectations, report, slides, earnings call, and transcript.
The earnings call reveals a mixed but generally optimistic outlook. Despite some short-term challenges, the company expects significant improvements in the second half of the year, driven by innovation and distribution gains. Share repurchases and a focus on high-growth brands like Quest and OWYN are positive indicators. The market cap suggests a moderate reaction, leading to a positive prediction.
Net Sales $340.2 million, essentially flat year-over-year. Quest net sales grew nearly 10%, driven by robust consumption growth of 12%, while Atkins and OWYN declined 17% and 3%, respectively. Reasons include robust consumption growth for Quest and declines in Atkins due to lost distribution at key retailers.
Gross Profit $109.9 million, declined 15.8% year-over-year. Gross margin was 32.3%, a decline of 590 basis points. Reasons include elevated inflationary costs, notably cocoa, and tariffs, partially offset by productivity and mix.
Adjusted EBITDA $55.6 million, down 20.6% year-over-year. Reasons include margin pressures from higher input costs and tariffs.
Net Income $25.3 million, a decline of 34% year-over-year. Reasons include margin challenges and one-time costs.
Diluted Earnings Per Share (EPS) $0.26, down from $0.38 year-over-year. Adjusted diluted EPS was $0.39, down from $0.49. Reasons include margin pressures and one-time costs.
Cash Flow from Operations $50.1 million, up from approximately $32 million last year. Reasons include improved working capital.
Marketing Expenses $29.7 million, declined 10.1% year-over-year. Reasons include a planned pullback in Atkins marketing, while Quest and OWYN marketing increased nearly 10%.
G&A Expenses $38 million, flat year-over-year. Excluding stock-based compensation and one-time costs, G&A declined 4.4% to $28.3 million due to cost synergies from the OWYN acquisition and cost management.
Share Repurchases 5 million shares repurchased for $100 million in Q1. Fiscal year-to-date, $150 million spent to repurchase over 7% of shares outstanding. Reasons include stock trading at attractive levels.
Quest Salty Snacks: Consumption up 40%, driven by distribution gains, velocity growth, and new flavors. Household penetration surpassed 10%, up 220 basis points year-over-year.
Quest Bars: Consumption flat year-over-year. New Overload platform and Taste Forward Crispy line introduced. Additional initiatives planned for the second half.
45-gram Protein Milkshake: Gained 8 ACV points during the quarter. Expanded placements across stores and new opportunities secured for winter and spring.
High Protein Donut: Launched initially on e-commerce and with a large mass retailer. ACV expected to ramp as retailers reset shelves.
Quest and OWYN: Double-digit growth driven by expanded distribution and marketing. Combined, they generated 71% of net sales.
Atkins: Consumption declined 19% due to lost distribution at key retailers. Efforts underway to modernize the brand and stabilize performance.
Productivity Program: Delivering results by reducing costs and ensuring a multiyear pipeline of initiatives. Expected to show clearer benefits in the second half.
Supply Chain Management: Extended supply coverage at favorable prices for key inputs like cocoa, expected to benefit P&L in late Q4 and fiscal 2027.
Share Buyback Program: Borrowed $150 million to accelerate share repurchases. Over 7% of common stock repurchased since the start of the year. Board authorized an additional $200 million for the program.
Atkins and GLP-1 Drugs: Pilot clinical study conducted to assess Atkins' effectiveness for consumers using GLP-1 drugs. Positive results observed, including muscle mass retention and digestive comfort.
Atkins Brand Decline: Consumption declined 19%, driven by lost distribution at several key retailers, accounting for 2/3 of the headwind. The brand faces challenges in stabilizing its business despite efforts to modernize and reposition.
OWYN Product Quality Issues: Lingering product quality issues have impacted retailer inventory levels and consumer perception, leading to slower consumption growth and challenges in rebuilding quality perception.
Gross Margin Decline: Gross margin declined 590 basis points year-over-year due to elevated inflationary costs, including cocoa and tariffs, which were only partially offset by productivity and mix improvements.
Tariffs Impact: Tariffs contributed to a 120 basis point decline in gross margin, adding approximately $4 million in costs during the quarter.
Economic and Input Cost Pressures: Elevated inflationary costs, particularly for cocoa and whey, continue to pressure margins and profitability.
Q2 Weakness Expected: Q2 is expected to be the weakest quarter for consumption and net sales growth due to price elasticities, lingering product quality issues, and challenging laps for Quest and OWYN.
Atkins and GLP-1 Drugs: The rise of GLP-1 drugs for weight loss presents a challenge to Atkins' core promise of weight management, requiring adaptation to maintain relevance.
Full Year Outlook: The company reaffirmed its full-year outlook for net sales and adjusted EBITDA. Net sales growth is expected to range from -2% to +2%, with growth from Quest and OWYN offset by declines in Atkins. Adjusted EBITDA is expected to range from -4% to +1% year-over-year.
Gross Margin: Gross margins are expected to decline by 100 to 150 basis points for the fiscal year. Sequential improvement in gross margin declines is expected in Q2, with Q4 gross margins expanding nearly 200 basis points year-over-year.
Second Half Performance: The company expects stronger top and bottom-line performance in the second half of the fiscal year, with net sales growth at the higher end of the full-year range. Gross margins in the second half are expected to be roughly in line with or slightly better than fiscal 2025 levels, with Q4 showing significant improvement.
Quest Brand: Quest is expected to deliver high single-digit consumption growth for the fiscal year. The brand will benefit from distribution gains, innovation launches, and increased marketing investments.
Atkins Brand: Atkins consumption is expected to decline by approximately 20% for the fiscal year, driven by distribution losses. The company is focusing on modernizing the brand and stabilizing its performance.
OWYN Brand: OWYN is expected to see slower consumption growth in Q2 due to initial price elasticities and lingering product quality issues. However, the brand is expected to benefit from increased marketing investments, distribution gains, and innovation in the second half.
Capital Expenditures: Capital expenditures for the fiscal year are expected to range from $30 million to $40 million, primarily for co-investment in additional capacity for the salty snacks business.
Share Repurchase Program: The company has repurchased over 7% of its common stock since the start of the fiscal year and has increased its share repurchase authorization by $200 million.
Share Buyback Program: The company borrowed an incremental $150 million during the quarter to accelerate its share buyback program. Since the start of the year, over 7% of the common stock has been repurchased. Additionally, the Board authorized a $200 million increase to the existing share repurchase program. The decision to repurchase stock reflects confidence in the company's long-term growth potential.
The earnings call reveals a mixed but generally optimistic outlook. Despite some short-term challenges, the company expects significant improvements in the second half of the year, driven by innovation and distribution gains. Share repurchases and a focus on high-growth brands like Quest and OWYN are positive indicators. The market cap suggests a moderate reaction, leading to a positive prediction.
The company demonstrates strong sales growth projections, particularly for OWYN and Quest, despite challenges with Atkins. Strategic initiatives in product placement and innovation are promising. However, declining gross margins and the OWYN issue are concerns. The company's balanced capital allocation and share buybacks add positive sentiment. The market cap suggests moderate stock volatility, leading to a positive forecast for the next two weeks.
The earnings call presented mixed signals: OWYN's strong growth and distribution expansion are positive, but Atkins' decline and gross margin pressures offset this. The Q&A revealed uncertainties regarding guidance and fiscal '26 performance, with management's vague responses adding to investor uncertainty. The market cap suggests moderate reactions, leading to a neutral prediction.
The earnings call summary highlights several positive factors: EPS exceeded expectations, a strategic acquisition of OWYN, and a $50 million share repurchase program. Despite competitive pressures and supply chain challenges, the positive EPS and acquisition of OWYN, which is expected to drive future growth, are strong indicators. The Q&A reveals some concerns about Atkins' sales guidance, but the company's proactive approach to product innovation and distribution expansion for OWYN suggests optimism. Given the company's market cap, these factors collectively suggest a positive stock price movement over the next two weeks.
All transcripts are sourced directly from the official live webcast or the company’s official investor relations website. We use the exact words spoken during the call with no paraphrasing of the core discussion.
Full verbatim transcripts are typically published within 4–12 hours after the call ends. Same-day availability is guaranteed for all S&P 500 and most mid-cap companies.
No material content is ever changed or summarized in the “Full Transcript” section. We only correct obvious spoken typos (e.g., “um”, “ah”, repeated 10 times”, or clear misspoken ticker symbols) and add speaker names/titles for readability. Every substantive sentence remains 100% as spoken.
When audio quality is poor or multiple speakers talk over each other, we mark the section instead of guessing. This ensures complete accuracy rather than introducing potential errors.
They are generated by a specialized financial-language model trained exclusively on 15+ years of earnings transcripts. The model extracts financial figures, guidance, and tone with 97%+ accuracy and is regularly validated against human analysts. The full raw transcript always remains available for verification.